Skip to main content

Table 2 Mean and median survival times for all treatment groups

From: Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab

Treatment

Dosage

Mean ± standard error

Median ± standard error

Number of mice

NaCl

 

52 ± 10

42 ± 13

10

Trastuzumab (Pooled)

20 - 250 μg

54 ± 5

47 ± 2

16

227Th-rituximab

400 kBq/kg

44 ± 5

49 ± 8

9

227Th- rituximab

600 kBq/kg

47 ± 5

36 ± 3

10

227Th-trastuzumab

200 kBq/kg

39 ± 2

38 ± 2

10

227Th-trastuzumab

400 kBq/kg

87 ± 7*

63 ± 3*

11

227Th-trastuzumab

600 kBq/kg

95 ± 3*

96 ± 3*

12

  1. *Significant difference between control and therapy.